Biotech - Press Releases

Date	Title	Company
01-May-2025	Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations	Nxera
30-Apr-2025	Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025	Domain Therapeutics
30-Apr-2025	Isomerase Enhances Process Innovation Capabilities for Protein Discovery and Production	Isomerase
29-Apr-2025	Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb	Andrew Lloyd Associates
28-Apr-2025	Single-use Bioprocessing: A Rapidly Growing Frontier in Biomanufacturing	futurewiseresearch
24-Apr-2025	Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers	Tessellate Bio
23-Apr-2025	Landmark BioVentures and G.CLIPS Biotech forge strategic alliance to address critical gaps in drug target engagement	Andrew Lloyd Associates
23-Apr-2025	Dr. Stephan Rietiker elected as new Chairman of the Board of MetrioPharm AG	MetrioPharm
23-Apr-2025	Biosensors Market Size to Grow at 8% CAGR by 2030, Driven by Wearables, AI, and Point-of-Care Diagnostics	Medi-Tech Insights
23-Apr-2025	Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange	Everest Medicines Limited
22-Apr-2025	AACR 2025: Meteor Biotech showcases CosmoSort, new class of spatial cell sorter enabling deeper translational cancer research	Andrew Lloyd Associates
22-Apr-2025	Carthera reaches recruitment milestone in SONOBIRD pivotal trial for recurrent glioblastoma	Andrew Lloyd Associates
22-Apr-2025	Novadip reports key nonclinical and interim clinical data for NVDX3, its off-the-shelf allogeneic product, in spine fusion	Andrew Lloyd Associates
21-Apr-2025	Biopharmaceutical Process Analytical Technology Market Size Set for Strong Growth at ~16% CAGR by 2030	Medi-Tech Insights
17-Apr-2025	Four new members elected to the Board of Directors of MetrioPharm AG	MetrioPharm
15-Apr-2025	Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025	Genmab
15-Apr-2025	Peninsula Pathology Network partners with Exponential-e to drive digital pathology transformation	Exponential-e
15-Apr-2025	Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025	Galapagos
15-Apr-2025	PLL Therapeutics enrolls first patient in phase I/II trial of drug candidate PLL001 for Amyotrophic Lateral Sclerosis (ALS)	Andrew Lloyd Associates
15-Apr-2025	Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA	HighTide Therapeutics, Inc.